Total Payments
$7,711
2024 Payments
$247.15
Companies
36
Transactions
305
Medicare Patients
1,001
Medicare Billing
$86,693
Payment Breakdown by Category
Food & Beverage$6,065 (78.6%)
Travel$1,647 (21.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,065 | 301 | 78.6% |
| Travel and Lodging | $1,647 | 4 | 21.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| LivaNova USA, Inc. | $1,722 | 5 | $0 (2022) |
| ABBVIE INC. | $1,059 | 41 | $0 (2024) |
| Avanir Pharmaceuticals, Inc. | $585.68 | 35 | $0 (2022) |
| SI-BONE, Inc. | $545.18 | 3 | $0 (2022) |
| Amgen Inc. | $346.23 | 18 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $331.45 | 19 | $0 (2024) |
| Allergan, Inc. | $291.46 | 25 | $0 (2022) |
| Biohaven Pharmaceutical Holding Company Ltd. | $277.05 | 9 | $0 (2022) |
| PFIZER INC. | $272.43 | 26 | $0 (2023) |
| EISAI INC. | $266.93 | 19 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $247.15 | 5 | ABBVIE INC. ($112.48) |
| 2023 | $956.03 | 56 | PFIZER INC. ($272.43) |
| 2022 | $4,304 | 121 | LivaNova USA, Inc. ($1,722) |
| 2021 | $2,204 | 123 | AbbVie Inc. ($509.26) |
All Payment Transactions
305 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/31/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $83.43 | General |
| Category: NEUROLOGY | ||||||
| 05/16/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: Central Nervous System | ||||||
| 05/01/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $18.99 | General |
| Category: Central Nervous System | ||||||
| 04/25/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $112.48 | General |
| Category: NEUROSCIENCE | ||||||
| 01/22/2024 | Otsuka America Pharmaceutical, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: NEUROLOGY | ||||||
| 11/30/2023 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $10.70 | General |
| Category: PAIN | ||||||
| 10/25/2023 | Ambu Inc. | — | Food and Beverage | Cash or cash equivalent | $17.91 | General |
| 09/11/2023 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $4.36 | General |
| Category: PAIN | ||||||
| 08/28/2023 | PFIZER INC. | PAXLOVID (Drug), NURTEC ODT, ZAVZPRET | Food and Beverage | In-kind items and services | $6.90 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 08/21/2023 | PFIZER INC. | PAXLOVID (Drug), NURTEC ODT, ZAVZPRET | Food and Beverage | In-kind items and services | $8.00 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 08/17/2023 | PFIZER INC. | PAXLOVID (Drug), NURTEC ODT, ZAVZPRET | Food and Beverage | In-kind items and services | $10.50 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 08/14/2023 | PFIZER INC. | PAXLOVID (Drug), NURTEC ODT, ZAVZPRET | Food and Beverage | In-kind items and services | $6.65 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 08/07/2023 | PFIZER INC. | PAXLOVID (Drug), NURTEC ODT, ZAVZPRET | Food and Beverage | In-kind items and services | $6.56 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 08/04/2023 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $7.50 | General |
| Category: PAIN | ||||||
| 08/03/2023 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: PAIN | ||||||
| 08/03/2023 | PFIZER INC. | PAXLOVID (Drug), NURTEC ODT, ZAVZPRET | Food and Beverage | In-kind items and services | $14.67 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 08/01/2023 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $9.21 | General |
| Category: PAIN | ||||||
| 07/31/2023 | Otsuka America Pharmaceutical, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $18.47 | General |
| Category: NEUROLOGY | ||||||
| 07/31/2023 | PFIZER INC. | PAXLOVID (Drug), NURTEC ODT, ZAVZPRET | Food and Beverage | In-kind items and services | $8.79 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 07/24/2023 | PFIZER INC. | PAXLOVID (Drug), NURTEC ODT, ZAVZPRET | Food and Beverage | In-kind items and services | $7.79 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 07/20/2023 | Biogen, Inc. | VUMERITY (Drug) | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: Neurology | ||||||
| 07/17/2023 | PFIZER INC. | PAXLOVID (Drug), NURTEC ODT, ZAVZPRET | Food and Beverage | In-kind items and services | $6.63 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 07/12/2023 | PFIZER INC. | PAXLOVID (Drug), NURTEC ODT, ZAVZPRET | Food and Beverage | In-kind items and services | $17.92 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 07/11/2023 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $14.69 | General |
| 06/28/2023 | Otsuka America Pharmaceutical, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $19.67 | General |
| Category: NEUROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 189 | 4,829 | $127,967 | $35,941 |
| 2022 | 12 | 360 | 586 | $88,613 | $22,212 |
| 2021 | 7 | 261 | 318 | $64,748 | $19,199 |
| 2020 | 6 | 191 | 218 | $37,601 | $9,340 |
Total Patients
1,001
Total Services
5,951
Medicare Billing
$86,693
Procedure Codes
30
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 12 | 4,600 | $69,000 | $22,706 | 32.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 132 | 167 | $41,378 | $9,318 | 22.5% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2023 | 11 | 24 | $9,984 | $1,960 | 19.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 15 | 15 | $5,489 | $1,578 | 28.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 19 | 23 | $2,116 | $378.40 | 17.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 137 | 176 | $39,587 | $9,779 | 24.7% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2022 | 12 | 39 | $16,224 | $2,932 | 18.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 24 | 24 | $9,119 | $2,584 | 28.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 22 | 22 | $6,791 | $2,118 | 31.2% |
| 87502 | Detection test by nucleic acid for multiple types influenza virus | Office | 2022 | 13 | 13 | $3,558 | $1,230 | 34.6% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 26 | 26 | $2,600 | $1,115 | 42.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 25 | 26 | $3,865 | $984.36 | 25.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 23 | 25 | $2,144 | $624.48 | 29.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 11 | 11 | $2,749 | $585.70 | 21.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 30 | 31 | $1,746 | $222.58 | 12.7% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2022 | 22 | 88 | $170.72 | $29.05 | 17.0% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2022 | 15 | 105 | $58.20 | $8.45 | 14.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 103 | 138 | $27,849 | $8,868 | 31.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 62 | 64 | $17,280 | $5,579 | 32.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 39 | 44 | $5,939 | $1,866 | 31.4% |
| 64615 | Injection of chemical for destruction of facial and neck nerve muscles on both sides of face | Office | 2021 | 15 | 24 | $9,984 | $1,778 | 17.8% |
| 87426 | Elisa detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2021 | 13 | 13 | $1,300 | $587.99 | 45.2% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 15 | 18 | $1,440 | $377.50 | 26.2% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 14 | 17 | $956.00 | $142.96 | 15.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 72 | 90 | $18,000 | $3,943 | 21.9% |
About Melissa Jackson, FNP
Melissa Jackson, FNP is a Family healthcare provider based in Madison, Mississippi. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/16/2017. The National Provider Identifier (NPI) number assigned to this provider is 1427562156.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Melissa Jackson, FNP has received a total of $7,711 in payments from pharmaceutical and medical device companies, with $247.15 received in 2024. These payments were reported across 305 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($6,065).
As a Medicare-enrolled provider, Jackson has provided services to 1,001 Medicare beneficiaries, totaling 5,951 services with total Medicare billing of $86,693. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Madison, MS
- Active Since 11/16/2017
- Last Updated 11/16/2017
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1427562156
Products in Payments
- VNS Therapy (Device) $1,722
- UBRELVY (Drug) $553.59
- NURTEC ODT (Drug) $471.74
- BOTOX (Biological) $434.71
- IFUSE IMPLANT (Device) $401.64
- Nuedexta (Drug) $373.86
- QULIPTA (Drug) $362.33
- Aimovig (Biological) $346.23
- NUEDEXTA (Drug) $285.21
- Fycompa (Drug) $266.93
- AUSTEDO (Drug) $177.16
- EPIDIOLEX (Drug) $176.78
- XCOPRI (Drug) $166.19
- AUBAGIO (Drug) $143.35
- VYEPTI (Biological) $129.59
- INGREZZA (Drug) $125.81
- NUPLAZID (Drug) $120.72
- AJOVY (Biological) $118.05
- Kcentra (Biological) $115.38
- COMIRNATY (Biological) $98.33
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Madison
Jill Easley
Family — Payments: $12,501
Family $12,501
Kelli Cranford, Np, NP
Family — Payments: $7,945
Family $7,945
Dean Whitley, Np, NP
Family — Payments: $7,484
Family $7,484
Brittany Hart, Fnp-C, FNP-C
Family — Payments: $6,900
Family $6,900
Mrs. Chassity Jones, Aprn, Fnp-Bc, APRN, FNP-BC
Family — Payments: $4,960
Family $4,960
Susan Furtwengler, Crnp, CRNP
Family — Payments: $4,387
Family $4,387